Abstract PD1-10: Immune Age Acceleration as a Biomarker for Immune-Related Adverse Events in Early Triple-Negative Breast Cancer Treated with Perioperative Pembrolizumab
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Authors: A. Alpert, M. Makarov, S. Mor, D. Aran, A. Shai
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129880594